A comparative study of bilateral subthalamic nucleus DBS in Parkinson’s disease in young versus old: A single institutional study
In this study STN DBS didn’t lead to any cognitive decline (MMSE) whatever is the age of patient during follow up. Bilateral STN DBS for Parkinson’s disease is equally effective in young and elderly patients.
Source: Journal of Clinical Neuroscience - Category: Neuroscience Source Type: research
More News: Brain | Carbidopa/Levodopa | Deep Brain Stimulation | Neurology | Neuroscience | Neurosurgery | Statistics | Study